Latest SCPS reports update at 2023-08-11: 2023-Q2 ∙ 2023-Q1 ∙ 2022-Q4

Scopus BioPharma SCPS

$ 0.18 -48.37%

Scopus BioPharma Financial Statements 2011-2024 | SCPS

Annual Financial Statements Scopus BioPharma

	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
Market Cap	3.8 M	12.5 M	137 M	-	-	-	-	-	-	-	-	-
Shares	21.1 M	17.3 M	13.4 M	-	-	-	-	-	-	-	-	-
Historical Prices	0.18	0.725	9.27	-	-	-	-	-	-	-	-	-
Net Income	-11.6 M	-27 M	-10.9 M	-2.69 M	-686 K	-	-	-	-	-	-	-
Revenue	-	-	-	-	-	-	-	-	-	-	-	-
Cost of Revenue	-	-	-	-	-	-	-	-	-	-	-	-
Gross Profit	-	-	-	-	-	-	-	-	-	-	-	-
Operating Income	-11.7 M	-27.6 M	-10.2 M	-2.69 M	-	-	-	-	-	-	-	-
Interest Expense	-	775 K	706 K	-	-	-	-	-	-	-	-	-
EBITDA	-11.7 M	-27.6 M	-10.2 M	-2.69 M	-686 K	-	-	-	-	-	-	-
Operating Expenses	11.7 M	27.6 M	10.2 M	-	-	-	-	-	-	-	-	-
General and Administrative Expenses	9.03 M	12.6 M	2.73 M	2.23 M	408 K	-	-	-	-	-	-	-

All numbers in USD currency

Quarterly Income Statement Scopus BioPharma

	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
Shares	39.7 M	30.4 M	21.1 M	21.1 M	21.1 M	21.1 M	21.1 M	17.1 M	16.2 M	15.3 M	14.6 M	14 M	12.9 M	12.5 M	12.5 M	12.5 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net Income	-2.62 M	-2.68 M	-	-1.9 M	-3.32 M	-4.66 M	-	-1.4 M	-15.6 M	-3.41 M	-	-1.16 M	-8.03 M	-626 K	-	-797 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cost of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Gross Profit	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Income	-	-	-	-1.9 M	-3.32 M	-4.66 M	-	-2.76 M	-15.3 M	-3.07 M	-	-875 K	-7.95 M	-619 K	-	-797 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Interest Expense	-	-	-	-	-	-	-	111 K	332 K	332 K	-	285 K	79.9 K	6.89 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
EBITDA	-	-	-	-1.9 M	-3.32 M	-4.66 M	-	-2.76 M	-15.3 M	-3.07 M	-	-874 K	-7.94 M	-619 K	-	-797 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Expenses	2.93 M	2.68 M	-	1.9 M	3.32 M	4.66 M	-	2.76 M	15.3 M	3.07 M	-	875 K	7.95 M	619 K	-	797 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
General and Administrative Expenses	936 K	1.07 M	-	981 K	2.67 M	4.29 M	-	2.68 M	1.73 M	1.82 M	-	806 K	711 K	569 K	-	715 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency